ERIC DOBMEIER Insider Trading $ATRA Atara Biotherapeutics, Inc.
Get free email notifications about insider trading for ERIC DOBMEIER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ERIC DOBMEIER. ERIC DOBMEIER is Chief Business Officer in SEATTLE GENETICS INC /WA ($SGEN) and Chief Operating Officer in SEATTLE GENETICS INC /WA ($SGEN) and Sr. VP, Corporate Development in SEATTLE GENETICS INC /WA ($SGEN) and V. P., Corporate Affairs in SEATTLE GENETICS INC /WA ($SGEN) and Vice President, in SEATTLE GENETICS INC /WA ($SGEN) and Director in STEMLINE THERAPEUTICS INC ($STML) and President, CEO in ADURO BIOTECH, INC. ($ADRO) and Director in Adaptive Biotechnologies Corp ($ADPT) and Director in Versartis, Inc. ($VSAR) and Director in Atara Biotherapeutics, Inc. ($ATRA).
ERIC DOBMEIER in Atara Biotherapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ERIC DOBMEIER: Director
Holdings: 28,000 shares
Current Value: $421,400
Latest Transaction: Jun 17 2020
$ATRA Market Capitalization: $434.34M
$ATRA Previous Close: $15.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ERIC DOBMEIER in Atara Biotherapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADPT, ARAV, ATRA, ADRO, SGEN, STML
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2020 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Option Exercise | A | 10.54 | 24,500 | 258,230 | 24,500 | |
| Jun 17 2020 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Grant | A | 0.00 | 8,000 | 0 | 28,000 | 20 K to 28 K (+40.00 %) |
| Jul 01 2019 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Option Exercise | A | 20.25 | 13,000 | 263,250 | 13,000 | |
| Jul 01 2019 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Grant | A | 0.00 | 4,000 | 0 | 20,000 | 16 K to 20 K (+25.00 %) |
| Jul 01 2019 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Buy | P | 19.50 | 2,000 | 39,000 | 16,000 | 14 K to 16 K (+14.29 %) |
| Jun 18 2018 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Option Exercise | A | 45.65 | 5,000 | 228,250 | 5,000 | |
| Jun 18 2018 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Grant | A | 0.00 | 1,500 | 0 | 14,000 | 12.5 K to 14 K (+12.00 %) |
| Jun 12 2017 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Option Exercise | A | 13.20 | 21,500 | 283,800 | 21,500 | |
| Jun 12 2017 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Grant | A | 0.00 | 5,000 | 0 | 12,500 | 7.5 K to 12.5 K (+66.67 %) |
| Jan 05 2017 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Option Exercise | A | 15.08 | 5,500 | 82,940 | 5,500 | |
| Jan 05 2017 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Grant | A | 0.00 | 2,000 | 0 | 7,500 | 5.5 K to 7.5 K (+36.36 %) |
| Mar 17 2016 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Buy | P | 13.86 | 3,000 | 41,565 | 5,500 | 2.5 K to 5.5 K (+120.00 %) |
| Jan 05 2016 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Option Exercise | A | 24.05 | 10,500 | 252,525 | 10,500 | |
| Dec 17 2015 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Buy | P | 22.00 | 2,500 | 55,000 | 2,500 | 0 to 2.5 K |
| Mar 30 2015 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Option Exercise | A | 34.90 | 25,000 | 872,500 | 25,000 |
Page: 1